Clinical Trials
8 trialsNCT02104011 2026-05-19
STBETA
University Hospital, Bordeaux
Phase 2 Completed
NCT05161494 2026-05-07
GAGA
Universiteit Antwerpen
Completed
NCT05864846 2026-04-27
EpiCom
Jazz Pharmaceuticals
Phase 4 Completed
NCT06311474 2026-03-18
RAINBOW
University of California, Los Angeles
Phase NA Completed
NCT07327164 2026-01-09
Precision Medicine for Neurocutaneous Syndromes in Western China
West China Hospital
Completed
NCT05626634 2025-12-03
Open-label, Long-term Safety Study of LP352 in Subjects With Developmental and Epileptic Encephalopathy
Longboard Pharmaceuticals
Phase 2 Completed
NCT06975605 2025-11-18
Phase 1, Open-label, Drug-drug Interaction Study to Assess Effect Between Radiprodil and the Co-administered Drugs.
GRIN Therapeutics, Inc.
Phase 1 Completed
NCT05323734 2025-07-11
Adjunctive GNX Treatment Compared With Placebo in Children and Adults With TSC-related Epilepsy
Marinus Pharmaceuticals
Phase 3 Completed